Development and External Validation of a mpMRI- and ISUP-Based Add-on Prediction Tool to Identity Prostate Cancer Candidates for Pelvic Lymph Node Dissection.

To expand the current prediction tools for lymph node invasion (LNI) in prostate cancer (PCa) patients with today’s state-of-the-art available tumor information, including multiparametric MRI (mpMRI)-based tumor (T) staging and detailed biopsy information.